User profiles for Moherndran Archary
 | Moherndran ArcharyPaediatric Infectious diseases specialist, UKZN Verified email at ukzn.ac.za Cited by 2327 |
Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the Cresting Wave
Context South Africa has the most HIV infections of any country in the world, yet little is
known about the adolescent continuum of care from HIV diagnosis through viral suppression. …
known about the adolescent continuum of care from HIV diagnosis through viral suppression. …
[HTML][HTML] Efficacy of NVX-CoV2373 Covid-19 vaccine against the B. 1.351 variant
V Shinde, S Bhikha, Z Hoosain, M Archary… - … England Journal of …, 2021 - Mass Medical Soc
Background The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …
[HTML][HTML] Systematic review of mHealth interventions for adolescent and young adult HIV prevention and the adolescent HIV continuum of care in low to middle income …
M Goldstein, M Archary, J Adong, JE Haberer… - AIDS and Behavior, 2023 - Springer
Adolescents and young adults (AYA) in low to middle income countries (LMIC) have poorer
outcomes along each step in the HIV continuum of prevention and care compared to …
outcomes along each step in the HIV continuum of prevention and care compared to …
Long-acting antiretrovirals and HIV treatment adherence
…, M Gandhi, RK Scott, LM Mofenson, M Archary… - The Lancet …, 2023 - thelancet.com
Intramuscular injection of long-acting cabotegravir and rilpivirine is a novel, long-acting
antiretroviral therapy (ART) combination approved for use as a fully suppressive regimen for …
antiretroviral therapy (ART) combination approved for use as a fully suppressive regimen for …
[HTML][HTML] Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study
…, MB Aletta, M Alice, T Aphane, M Archary… - The Lancet …, 2021 - thelancet.com
Background The interaction between COVID-19, non-communicable diseases, and chronic
infectious diseases such as HIV and tuberculosis is unclear, particularly in low-income and …
infectious diseases such as HIV and tuberculosis is unclear, particularly in low-income and …
[HTML][HTML] Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study
…, MB Aletta, M Alice, T Aphane, M Archary… - The Lancet Global …, 2021 - thelancet.com
Background The first wave of COVID-19 in South Africa peaked in July, 2020, and a larger
second wave peaked in January, 2021, in which the SARS-CoV-2 501Y.V2 (Beta) lineage …
second wave peaked in January, 2021, in which the SARS-CoV-2 501Y.V2 (Beta) lineage …
[HTML][HTML] Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised …
Background There is a paucity of data on COVID-19 vaccines in people living with HIV-1,
who could be at increased risk of severe illness and death from COVID-19. We evaluated the …
who could be at increased risk of severe illness and death from COVID-19. We evaluated the …
[HTML][HTML] Dolutegravir as first-or second-line treatment for HIV-1 infection in children
Background Children with human immunodeficiency virus type 1 (HIV-1) infection have
limited options for effective antiretroviral treatment (ART). Methods We conducted an open-label, …
limited options for effective antiretroviral treatment (ART). Methods We conducted an open-label, …
Nevirapine-versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 randomized …
…, K Angelidou, J Lindsey, M Archary… - Clinical Infectious …, 2016 - academic.oup.com
Background. The International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT)
P1060 study demonstrated short-term superiority of lopinavir/ritonavir (LPV/r) over …
P1060 study demonstrated short-term superiority of lopinavir/ritonavir (LPV/r) over …
[HTML][HTML] Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an …
Background Safe and potent antiretroviral medications in child-friendly formulations are
needed to treat young children living with HIV-1. We aimed to select dosing for a dispersible …
needed to treat young children living with HIV-1. We aimed to select dosing for a dispersible …